CBD Co. Exec Can't Dodge Investor's Fraud Claims
A Florida federal judge has denied a dismissal bid brought by the chief financial officer of CBD company Apotheca Biosciences Inc. in a suit accusing the company of conning an investor...To view the full article, register now.
Already a subscriber? Click here to view full article